Site-specific regulation of the epithelial sodium channel (ENaC) and the renal outer medullary K+ channel (ROMK) in the aldosterone-sensitive distal nephron (ASDN)

醛固酮敏感远端肾单位 (ASDN) 中上皮钠通道 (ENaC) 和肾外髓 K 通道 (ROMK) 的位点特异性调节

基本信息

项目摘要

Pathophysiological disturbances of Na+ or K+ homeostasis result in potentially life threatening disorders. This justifies the need to investigate cellular and molecular mechanisms involved in renal Na+ and K+ handling. The aldosterone-sensitive distal nephron (ASDN) comprises the late distal convoluted tubule (DCT2), connecting tubule (CNT), cortical collecting duct (CCD) and its distal parts. In the ASDN the epithelial sodium channel (ENaC) and the renal outer medullary K channel (ROMK) are critically important for the final adjustment of tubular Na+ absorption and K+ secretion, respectively. Aldosterone stimulates ENaC through the mineralocorticoid receptor (MR). This promotes tubular Na+ absorption and enhances the electrical driving force for ROMK mediated renal K+ secretion. Recent evidence supports the idea that ENaC and ROMK are expressed and regulated in a site-specific manner. This has important implications for Na+ homeostasis and blood pressure control as well as for K+ homeostasis. This renewal proposal is a logical continuation of our current project with a focus on patch-clamp studies in microdissected murine renal tubules. In addition, we will use a differentiated mouse CCD cell line (mCCDcl1) and native mouse distal colon in a comparative approach to reveal common and tissue-specific regulatory mechanisms of ENaC mediated Na+ transport. Based on published findings and preliminary experiments, we have two key objectives: (1) Identify common and distinct mechanisms of ENaC regulation in DCT2/CNT versus CNT/CCD; (2) Explore site-specific mechanisms of ROMK regulation in the distal nephron. Whole-cell and outside-out patch-clamp recordings will be performed in the transitional zones between DCT2 and early CNT (DCT2/CNT) and between late CNT and early cortical collecting duct (CNT/CCD). In combination with transgenic mouse models this provides a powerful approach to address unresolved physiological questions regarding the site-specific regulation of ENaC and ROMK in native tubules. In particular, we will use inducible nephron-specific MR deficient (MR KO) mice, a nephron specific glucocorticoid receptor (GR) deficient mouse model and angiotensin II type 1A (AT1A) receptor deficient (Agtr1A-/-) mice to explore the differential effects of MR, GR and AT1A deficiency on ENaC and ROMK activity in DCT2/CNT versus CNT/CCD. Recent evidence suggest that mTORC2 plays a role in ENaC regulation in response to changes in dietary K+ intake and local [K+]. To explore the role of mTORC2 in site-specific ENaC and ROMK regulation, we will use a novel mouse model (TRKO mice) with doxycycline-inducible tubular specific mTORC2 deficiency. With the experiments detailed in our project proposal, we expect to obtain new findings regarding the mechanisms involved in the site-specific regulation and function of ENaC and ROMK. This will enhance our understanding of the physiological interplay of these channels in Na+ and K+ homeostasis.
Na+或K+体内平衡的病理生理紊乱会导致潜在的危及生命的疾病。这证明有必要研究参与肾脏Na+和K+处理的细胞和分子机制。醛固酮敏感远端肾元(ASDN)包括晚期远曲小管(DCT2)、连接小管(CNT)、皮质集管(CCD)及其远端部分。在ASDN中,上皮钠通道(ENaC)和肾外髓K通道(ROMK)分别对小管Na+吸收和K+分泌的最终调节至关重要。醛固酮通过矿物皮质激素受体(MR)刺激ENaC。这促进了小管Na+的吸收,增强了ROMK介导的肾K+分泌的电驱动力。最近的证据支持ENaC和ROMK以特定位点的方式表达和调节的观点。这对Na+内稳态和血压控制以及K+内稳态具有重要意义。这项更新建议是我们当前项目的逻辑延续,重点是微解剖小鼠肾小管的膜片钳研究。此外,我们将使用分化的小鼠CCD细胞系(mCCDcl1)和天然小鼠远端结肠进行比较,以揭示ENaC介导的Na+转运的共同和组织特异性调节机制。基于已发表的研究结果和初步实验,我们有两个关键目标:(1)确定DCT2/CNT与CNT/CCD中ENaC调控的共同和独特机制;(2)探索远端肾元中ROMK调控的位点特异性机制。将在DCT2和早期CNT (DCT2/CNT)以及晚期CNT和早期皮质集管(CNT/CCD)之间的过渡区域进行全细胞和外向膜片钳记录。结合转基因小鼠模型,这为解决有关天然小管中ENaC和ROMK的位点特异性调节的未解决的生理问题提供了强有力的方法。特别是,我们将使用诱导肾细胞特异性MR缺陷(MR KO)小鼠,肾细胞特异性糖皮质激素受体(GR)缺陷小鼠模型和血管紧张素II型1A (AT1A)受体缺陷(Agtr1A-/-)小鼠来探索MR, GR和AT1A缺陷对DCT2/CNT与CNT/CCD中ENaC和ROMK活性的差异影响。最近的证据表明,mTORC2在ENaC调节中发挥作用,以响应饮食K+摄入量和局部[K+]的变化。为了探索mTORC2在位点特异性ENaC和ROMK调控中的作用,我们将使用一种新型小鼠模型(TRKO小鼠),该模型具有强力霉素诱导的管状特异性mTORC2缺陷。通过我们项目提案中详细的实验,我们希望获得有关ENaC和ROMK的位点特异性调节和功能的机制的新发现。这将增强我们对这些通道在Na+和K+稳态中的生理相互作用的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Christoph Korbmacher其他文献

Professor Dr. Christoph Korbmacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
  • 批准号:
    82371711
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
花胶鱼类物种Species-specific PCR和Multiplex PCR鉴定体系研究
  • 批准号:
    31902373
  • 批准年份:
    2019
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
Dravet综合征基因突变分析及突变来源研究
  • 批准号:
    81171221
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
睾丸特异性新基因TSC29的表达调控机制及其功能研究
  • 批准号:
    81170613
  • 批准年份:
    2011
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目
RNA结合蛋白CUG-BP1对于mRNA降解的调控机制研究
  • 批准号:
    31000570
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
新生隐球菌减数分裂特异性基因ISC10的生理功能研究
  • 批准号:
    30970130
  • 批准年份:
    2009
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目
寻找精神分裂症的调节性遗传变异
  • 批准号:
    30870899
  • 批准年份:
    2008
  • 资助金额:
    45.0 万元
  • 项目类别:
    面上项目

相似海外基金

Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies
使用位点特异性抗体识别 O-GlcNAc 修饰蛋白
  • 批准号:
    10697563
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
In situ and real-time readout of nuclear mechanotransduction via single cell mechanics and site-specific fluorescence reporting
通过单细胞力学和位点特异性荧光报告原位实时读出核力转导
  • 批准号:
    10745440
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
  • 批准号:
    10668492
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Defining the role of site-specific proteolysis in innate defense signaling
定义位点特异性蛋白水解在先天防御信号传导中的作用
  • 批准号:
    10500999
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Defining the role of site-specific proteolysis in innate defense signaling
定义位点特异性蛋白水解在先天防御信号传导中的作用
  • 批准号:
    10650829
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights
人类基因调控的位点特异性控制以获得治疗上适用的机制见解
  • 批准号:
    10282969
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights
人类基因调控的位点特异性控制以获得治疗上适用的机制见解
  • 批准号:
    10488643
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Site-specific epigenetic activation of TP53 to improve cancer therapy
TP53 的位点特异性表观遗传激活可改善癌症治疗
  • 批准号:
    10258179
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights (R35GM143532)
人类基因调控的位点特异性控制以获得治疗上适用的机制见解(R35GM143532)
  • 批准号:
    10807287
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Site-specific control of human gene regulation for therapeutically applicable mechanistic insights
人类基因调控的位点特异性控制以获得治疗上适用的机制见解
  • 批准号:
    10640172
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了